Measuring RNFL thickness

Article

Operator-dependent centring and automatic centring retinal nerve fibre layer (RNFL) thickness measurement patterns (RNFL3.45 and NHM4) have been shown to be in good agreement.

Operator-dependent centring and automatic centring retinal nerve fibre layer (RNFL) thickness measurement patterns (RNFL3.45 and NHM4) have been shown to be in good agreement, according to a study published in Clinical and Experimental Ophthalmology.

Dr Shuning Li et al., Beijing Ophthalmology and Visual Science Laboratory, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, China, conducted a cross-sectional observational study on 153 eyes of 149 patients. RNFL3.45 and NHM4 were used to measure retinal nerve fibre layer thickness three times daily. The outcome measures were Student's paired t-test, intra-class correlation coefficient, and coefficient of variation, test–retest viability, Pearson's correlation coefficient and Bland–Altman analysis of RNFL thickness measurements.

Paired t-testing demonstrated that the difference between RNFL3.45 and NHM4 measurements were statistically significant in the severe glaucoma group. The Pearson's correlation test revealed a strong correlation of the mean RNFL.

Bland–Altman plots revealed that the differences between RNFL3.45 and NHM4 were larger at thinner RNFL values, but smaller at thicker RNFL values. The intra-class correlation coefficient for RNFL3.45 in control patients and glaucoma patients was 0.990 and 0.997, respectively. For NHM4 the intra-class correlation coefficient was 0.989 and 0.995 for the control patients and glaucoma patients, respectively.

RNFL3.45 and NHM4 are both sufficient methods for RNFL thickness.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.